Novogen Ltd. (NVGN)

[stocktrademan]

$NVGN recent news/filings

bullish
quick trade

## source: finance.yahoo.com

Thu, 02 Apr 2015 02:49:00 GMT ~ Novogen Engages Leading US Investor Relations Firm

[PR Newswire] - SYDNEY, April 2, 2015 /PRNewswire/ -- Novogen Ltd (ASX:NRT NASDAQ:NVGN) today announced it has appointed US-based public relations firm, PCG Advisory (PCG), to drive the Company's investor-awareness program ...

read full: http://finance.yahoo.com/news/novogen-engages-leading-us-investor-024900307.html
*********************************************************

Mon, 30 Mar 2015 08:52:13 GMT ~ Novogen shares surge on drug data

[Other] - Shares in drug discoverer Novogen have surged after the company said its experimental anti-cancer drug Cantrixil killed human ovarian stem cells. Novogen, which is listed on the Australian Securities Exchange ...

read full: http://au.finance.yahoo.com/news/novogen-shares-surge-drug-data-002519888.html
*********************************************************

Mon, 30 Mar 2015 00:53:00 GMT ~ Yale University and Novogen Release Data on Cantrixil Mode of Action

[PR Newswire] - NASDAQ:NVGN) and its subsidiary, CanTx, Inc., and Yale University, on March 27 released pre-clinical data on experimental anti-cancer drug, Cantrixil. The data was presented as an oral presentation by Professor Gil Mor MD PhD of Yale Medical School to the 62nd Annual Scientific Meeting of the Society of Reproductive Investigation in San Francisco, CA. In both in vitro and in animal studies, Cantrixil, has proved highly effective at killing human ovarian stem (tumor-initiating) cells, cells that otherwise are highly resistant to standard of care cytotoxic drugs and which generally are believed to be responsible for diseases recurrence following initial therapy. In addition, Cantrixil blocks the survival pathway pERK. The combination of these two cellular effects (down-regulation of pro-survival and up-regulation of pro-death pathways) provides a unique advantage to target chemo-resistant cancer stem cells.

read full: http://finance.yahoo.com/news/yale-university-novogen-release-data-005300956.html
*********************************************************

Wed, 18 Mar 2015 11:00:00 GMT ~ Potential of Anisina to Become Major New Chemotherapy Confirmed by Coda Study

[PR Newswire] - SYDNEY, March 18, 2015 /PRNewswire/ -- Novogen announced on 18th March, 2015 that one of its oncology pipeline drug candidates, Anisina (ATM-3507), has achieved a major milestone in its development, confirming the concept that comprehensive destruction of a cancer cell's cytoskeleton can deliver a powerful anti-cancer effect. Dr Kelly was interviewed by Channel 7 health reporter, Dr Andrew Rochford about Anisina's potential. To view the interview click here…… or visit the Novogen website. The most commonly used drugs in chemotherapy target the cytoskeleton by destabilising one of its two key components, the microtubules. The rationale behind the development of Anisina was that the anti-mitotic drugs only do half the job, because they leave the other major component of the cytoskeleton, the microfilaments, intact.

read full: http://finance.yahoo.com/news/potential-anisina-become-major-chemotherapy-110000656.html
*********************************************************

Tue, 10 Mar 2015 04:28:00 GMT ~ Sky News, Helen Dalley interviews Dr Graham Kelly

[PR Newswire] - SYDNEY, March 10, 2015 /PRNewswire/ -- Novogen Ltd (ASX: 'NRT'; Nasdaq: 'NVGN') CEO , Dr Graham Kelly, PhD, was interviewed by Sky News ' , Helen Dalley about the breakthrough brain cancer drug being developed ...

read full: http://finance.yahoo.com/news/sky-news-helen-dalley-interviews-042800464.html
*********************************************************

$NVGN charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com



$NVGN company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/NVGN/company-info
Ticker: $NVGN
OTC Market Place: Not Available
CIK code: 0001075880
Company name: Novogen Ltd.
Company website: http://www.novogen.com
Incorporated In: Australia

$NVGN share structure

## source: otcmarkets.com

Market Value: $332,589 a/o Apr 06, 2015
Shares Outstanding: 2,018,137 a/o Jan 03, 2011
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value

$NVGN extra dd links

Company name: Novogen Ltd.
Company website: http://www.novogen.com

## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=NVGN+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=NVGN+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=NVGN+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/NVGN/news - http://finance.yahoo.com/q/h?s=NVGN+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/NVGN/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/NVGN/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=NVGN+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/NVGN
DTCC (dtcc.com): http://search2.dtcc.com/?q=Novogen+Ltd.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Novogen+Ltd.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Novogen+Ltd.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.novogen.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.novogen.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.novogen.com

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/NVGN
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001075880&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/NVGN/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/NVGN/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=NVGN&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=NVGN
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/NVGN/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=NVGN+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=NVGN+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=NVGN
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=NVGN
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=NVGN+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/NVGN/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=NVGN+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/NVGN.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=NVGN
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/NVGN/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/NVGN
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/NVGN
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/NVGN:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=NVGN
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=NVGN



$NVGN DD Notes ~ http://www.ddnotesmaker.com/NVGN